Approvals/TGA/CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial

Approved

STANDARD

CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial

Dr Reddys Laboratories Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 075cccec610caaae
Product Name: CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial
Artg Id: 287927
Artg Name: CABAZITAXEL-DRLA cabazitaxel 60 mg/1.5 mL concentrated injection vial
Sponsor: Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path: /organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date: 2018-07-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

075cccec610caaae

Type

Standard